Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab and Bevacizumab in Hepatocellular Carcinoma”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Looking for participantsNCT06695026
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Rznomics, Inc. 45
Large-scale testing (Phase 3)Looking for participantsNCT04803994
What this trial is testing

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 434
Testing effectiveness (Phase 2)Looking for participantsNCT06294548
What this trial is testing

Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Who this might be right for
Hepatocellular Carcinoma
University of Alabama at Birmingham 45
Not applicableLooking for participantsNCT07365930
What this trial is testing

NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 350
Testing effectiveness (Phase 2)Study completedNCT04170556
What this trial is testing

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 69
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06984718
What this trial is testing

A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC

Who this might be right for
HCCHepatocellular Carcinoma
Akeso 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04770896
What this trial is testing

Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab

Who this might be right for
Unresectable Hepatocellular Carcinoma
Hoffmann-La Roche 557
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05908916
What this trial is testing

Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yonsei University 51
Testing effectiveness (Phase 2)Looking for participantsNCT06789757
What this trial is testing

The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Inova Health Care Services 19
Large-scale testing (Phase 3)Ended earlyNCT04732286
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 100
Not applicableLooking for participantsNCT06961526
What this trial is testing

Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Who this might be right for
Esophageal and/or Gastric VaricesHepatocellular Carcinoma (HCC)
Tanta University 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018947
What this trial is testing

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Who this might be right for
Resectable Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 90
Testing effectiveness (Phase 2)Looking for participantsNCT04563338
What this trial is testing

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung Cancer MetastaticLiver Metastases
University Health Network, Toronto 36
Testing effectiveness (Phase 2)Looking for participantsNCT05690048
What this trial is testing

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

Who this might be right for
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill 48
Testing effectiveness (Phase 2)Looking for participantsNCT06605664
What this trial is testing

Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab

Who this might be right for
Hepatocellular Carcinoma (HCC)
Chang Gung Memorial Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT04727307
What this trial is testing

Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Montpellier 202
Testing effectiveness (Phase 2)Looking for participantsNCT06339424
What this trial is testing

Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chang Gung Memorial Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07010497
What this trial is testing

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Asan Medical Center 33
Large-scale testing (Phase 3)Not Yet RecruitingNCT06680258
What this trial is testing

TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tempest Therapeutics 740
Load More Results